77-Year-Old Gets New Heart Valve Without Repeat Open-Heart Surgery at Paras Health Panchkula
Minimally invasive valve-in-valve TAVI helps high-risk patient avoid second major cardiac surgery; hospital completes 65 TAVI procedures
Panchkula 8 September ( Ranjeet Singh Dhaliwal ) : Paras Health Panchkula has successfully treated a 77-year-old woman with a failed surgical aortic valve through a minimally invasive valve-in-valve Transcatheter Aortic Valve Implantation (TAVI) procedure. Performed on September 2, the procedure allowed the high-risk elderly patient to receive a new heart valve without undergoing another open-heart surgery. The case also marked the hospital’s 65th TAVI procedure. The patient had diabetes and hypertension and had undergone Surgical Aortic Valve Replacement (SAVR) in 2020, with a 19 mm St. Jude Epic bioprosthetic valve implanted. After remaining stable for nearly five years, she developed progressively worsening breathlessness and occasional episodes of transient loss of consciousness.
Evaluation at Paras Health Panchkula showed degeneration of the surgical bioprosthetic valve, resulting in symptomatic severe aortic stenosis. Considering her advanced age, previous heart surgery and other medical conditions, repeat open-heart valve replacement was considered high risk. Following a detailed assessment and Heart Team discussion, the doctors opted for valve-in-valve TAVI. A 23 mm Medtronic Evolut PRO+ self-expanding valve was successfully implanted through a blood vessel accessed from the groin. The procedure took around one hour and was completed without opening the chest. The patient tolerated the procedure well, experienced no post-procedure complications and recovered satisfactorily.
Dr. (Maj. Gen.) Naveen Aggarwal, Chairman – Structural Heart Disease & EP Studies, Paras Health Panchkula, said that valve-in-valve TAVI can provide an effective minimally invasive option for appropriately selected patients, particularly those at higher risk for repeat surgery. He emphasised the importance of timely evaluation when patients with previously implanted surgical valves develop symptoms such as breathlessness, fatigue or fainting.
Dr. Pankaj Mittal, Facility Director, Paras Health Panchkula, said the successful procedure marked the hospital’s 65th TAVI, reflecting its growing experience in complex structural heart interventions. He added that the hospital remains focused on strengthening advanced cardiac care and providing minimally invasive treatment options for complex heart conditions. The case highlights the evolving role of valve-in-valve TAVI in patients with failed surgical bioprosthetic valves and offers a less invasive alternative to repeat surgery in carefully selected high-risk patients.

Comments
Post a Comment